Literature DB >> 26414976

Measuring Treatment Outcomes in Comorbid Insomnia and Fibromyalgia: Concordance of Subjective and Objective Assessments.

Jennifer M Mundt1, Earl C Crew1, Kendra Krietsch1, Alicia J Roth1, Karlyn Vatthauer1, Michael E Robinson1, Roland Staud2, Richard B Berry3, Christina S McCrae4.   

Abstract

STUDY
OBJECTIVES: In insomnia, actigraphy tends to underestimate wake time compared to diaries and PSG. When chronic pain co-occurs with insomnia, sleep may be more fragmented, including more movement and arousals. However, individuals may not be consciously aware of these arousals. We examined the baseline concordance of diaries, actigraphy, and PSG as well as the ability of each assessment method to detect changes in sleep following cognitive behavioral therapy for insomnia (CBT-I).
METHODS: Adults with insomnia and fibromyalgia (n = 113) were randomized to CBT-I, CBT for pain, or waitlist control. At baseline and posttreatment, participants completed one night of PSG and two weeks of diaries/actigraphy.
RESULTS: At baseline, objective measures estimated lower SOL, higher TST, and higher SE than diaries (ps < 0.05). Compared to PSG, actigraphic estimates were higher for SOL and lower for WASO (ps < 0.05). Repeated measures ANOVAs were conducted for the CBT-I group (n = 15), and significant method by time interactions indicated that the assessment methods differed in their sensitivity to detect treatment-related changes. PSG values did not change significantly for any sleep parameters. However, diaries showed improvements in SOL, WASO, and SE, and actigraphy also detected the WASO and SE improvements (ps < 0.05).
CONCLUSIONS: Actigraphy was generally more concordant with PSG than with diaries, which are the recommended assessment for diagnosing insomnia. However, actigraphy showed greater sensitivity to treatment-related changes than PSG; PSG failed to detect any improvements, but actigraphy demonstrated changes in WASO and SE, which were also found with diaries. In comorbid insomnia/fibromyalgia, actigraphy may therefore have utility in measuring treatment outcomes.
© 2015 American Academy of Sleep Medicine.

Entities:  

Keywords:  actigraphy; assessment; chronic pain; clinical trial; cognitive behavioral therapy; fibromyalgia; insomnia; polysomnography

Mesh:

Year:  2016        PMID: 26414976      PMCID: PMC4751413          DOI: 10.5664/jcsm.5488

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN: 1550-9389            Impact factor:   4.062


  33 in total

1.  Sleep disturbance and nonmalignant chronic pain: a comprehensive review of the literature.

Authors:  L A Menefee; M J Cohen; W R Anderson; K Doghramji; E D Frank; H Lee
Journal:  Pain Med       Date:  2000-06       Impact factor: 3.750

2.  Evaluation of actigraphy and automated telephoned questionnaires to assess hypnotic effects in insomnia.

Authors:  S J Wilson; A S Rich; N C Rich; J Potokar; D J Nutt
Journal:  Int Clin Psychopharmacol       Date:  2004-03       Impact factor: 1.659

3.  Validity of activity-based devices to estimate sleep.

Authors:  Allison R Weiss; Nathan L Johnson; Nathan A Berger; Susan Redline
Journal:  J Clin Sleep Med       Date:  2010-08-15       Impact factor: 4.062

4.  Light sleep and sleep time misperception - relationship to alpha-delta sleep.

Authors:  Denis Martinez; Tiago Cataldo Breitenbach; Maria do Carmo Sfreddo Lenz
Journal:  Clin Neurophysiol       Date:  2010-02-12       Impact factor: 3.708

5.  Determination of sleep and wakefulness with the actigraph data analysis software (ADAS).

Authors:  G Jean-Louis; H von Gizycki; F Zizi; J Fookson; A Spielman; J Nunes; R Fullilove; H Taub
Journal:  Sleep       Date:  1996-11       Impact factor: 5.849

6.  A comparison of actigraphy and polysomnography in older adults treated for chronic primary insomnia.

Authors:  Børge Sivertsen; Siri Omvik; Odd E Havik; Ståle Pallesen; Bjørn Bjorvatn; Geir Høstmark Nielsen; Sivert Straume; Inger Hilde Nordhus
Journal:  Sleep       Date:  2006-10       Impact factor: 5.849

7.  Nightly analyses of subjective and objective (actigraphy) measures of sleep in fibromyalgia syndrome: what accounts for the discrepancy?

Authors:  Akiko Okifuji; Bradford D Hare
Journal:  Clin J Pain       Date:  2011-05       Impact factor: 3.442

8.  The London Fibromyalgia Epidemiology Study: comparing the demographic and clinical characteristics in 100 random community cases of fibromyalgia versus controls.

Authors:  K P White; M Speechley; M Harth; T Ostbye
Journal:  J Rheumatol       Date:  1999-07       Impact factor: 4.666

9.  Comorbidity of chronic insomnia with medical problems.

Authors:  Daniel J Taylor; Laurel J Mallory; Kenneth L Lichstein; H Heith Durrence; Brant W Riedel; Andrew J Bush
Journal:  Sleep       Date:  2007-02       Impact factor: 5.849

10.  Practice parameters for the use of actigraphy in the assessment of sleep and sleep disorders: an update for 2007.

Authors:  Timothy Morgenthaler; Cathy Alessi; Leah Friedman; Judith Owens; Vishesh Kapur; Brian Boehlecke; Terry Brown; Andrew Chesson; Jack Coleman; Teofilo Lee-Chiong; Jeffrey Pancer; Todd J Swick
Journal:  Sleep       Date:  2007-04       Impact factor: 5.849

View more
  5 in total

1.  Agreement between actigraphic and polysomnographic measures of sleep in adults with and without chronic conditions: A systematic review and meta-analysis.

Authors:  Samantha Conley; Andrea Knies; Janene Batten; Garrett Ash; Brienne Miner; Youri Hwang; Sangchoon Jeon; Nancy S Redeker
Journal:  Sleep Med Rev       Date:  2019-05-13       Impact factor: 11.609

2.  Cognitive and Behavioral Interventions to Improve Sleep in School-Age Children and Adolescents: A Systematic Review and Meta-Analysis.

Authors:  Lie Åslund; Filip Arnberg; Marie Kanstrup; Mats Lekander
Journal:  J Clin Sleep Med       Date:  2018-11-15       Impact factor: 4.062

3.  Use of Actigraphy for the Evaluation of Sleep Disorders and Circadian Rhythm Sleep-Wake Disorders: An American Academy of Sleep Medicine Systematic Review, Meta-Analysis, and GRADE Assessment.

Authors:  Michael T Smith; Christina S McCrae; Joseph Cheung; Jennifer L Martin; Christopher G Harrod; Jonathan L Heald; Kelly A Carden
Journal:  J Clin Sleep Med       Date:  2018-07-15       Impact factor: 4.062

4.  Utilization of Overnight Pulse Oximetry in Fibromyalgia Patients.

Authors:  Stephanie D Clark; Bradley R Salonen; Neha V Reddy Bs; Arya B Mohabbat
Journal:  Glob Adv Health Med       Date:  2019-05-01

5.  Is Fibromyalgia Syndrome a Neuropathic Pain Syndrome?

Authors:  Meryem Kösehasanoğullari; Nihan Erdinç Gündüz; Elif Akalin
Journal:  Arch Rheumatol       Date:  2018-11-30       Impact factor: 1.472

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.